Quantcast

Latest Management of prostate cancer Stories

2014-07-09 08:28:47

LONDON, ON, July 9, 2014 /CNW/ - Focal Healthcare (Focal) was founded as a spin-off company out of the Centre for Imaging Technology Commercialization (CIMTEC). Focal is developing and marketing MRI-Ultrasound Fusion Biopsy and Therapy systems that have strong potential to become the new "gold standard" in prostate care by capitalizing on CIMTEC's unique intellectual property, as well as its extensive technology development and commercialization expertise in the medical imaging field....

2014-06-04 12:29:19

Skyline Radiation Oncology, first in state to use Clarity, now also offers precise stereotactic radiotherapy for prostate cancer due to increased disease targeting confidence TUSTIN, Calif., June 4, 2014 /PRNewswire/ -- Skyline Radiation Oncology's acquisition of Elekta's Clarity® soft tissue visualization system is enabling physicians to continuously track the motion of the prostate during the delivery of radiation therapy. With continuous intrafractional image guidance, Skyline is...

2014-05-27 12:30:29

CHARLOTTE, N.C., May 27, 2014 /PRNewswire/ -- Medical device manufacturer SonaCare Medical reports continuing strong European sales as well as a positive outlook in light of official guideline changes for prostate cancer therapy. The company has further invested in the European market by adding its newest generation high intensity focused ultrasound ("HIFU") equipment to the HIFU center of excellence at University College of London. Following a strong 2013 with six thermal ablation...

2014-05-20 16:26:25

Two Studies Presented at 2014 AUA Annual Meeting SAN DIEGO, May 20, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced the presentation of data showing that its Decipher® Prostate Cancer Classifier, a genomic test capable of predicting metastatic prostate cancer, was able to identify patients that may be spared of radiation therapy after prostate surgery who would have been otherwise classified as high risk based on current clinical practice guidelines. In a separate study,...

2014-05-20 08:34:18

New studies highlight impact of certain conditions on prostate cancer severity, role diet may play in etiology ORLANDO, Fla., May 20, 2014 /PRNewswire-USNewswire/ -- Three new studies featuring the impact of dietary and lifestyle factors on prostate cancer will be presented during the 109(th) Annual Scientific Meeting of the American Urological Association (AUA). The research will be highlighted by study authors during a special press conference at the Orange County Convention Center...

2014-05-17 12:20:17

Panel discusses long-term effect on quality of life ORLANDO, Fla., May 17, 2014 /PRNewswire-USNewswire/ -- A series of studies evaluating the outcomes, benefits, concerns and quality of life of men undergoing active surveillance for prostate cancer will be presented to media at a special press conference during the 2014 Annual Scientific Meeting of the American Urological Association (AUA). Stacy Loeb, MD, assistant professor at New York University, New York, NY, will moderate the session,...

2014-05-16 16:24:58

Oncotype DX® Prostate Cancer Test Enables More Precise Risk Assessment and Significantly Increases Number of Low-Risk Patients Who Can Confidently Choose Active Surveillance REDWOOD CITY, Calif., May 16, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) announced today that groundbreaking results from three studies of the Oncotype DX(®) prostate cancer test were published in European Urology. The peer-reviewed publication highlights studies that focus on addressing the need...

2014-05-08 08:32:48

SAN DIEGO, May 8, 2014 /PRNewswire/ -- GenomeDx Biosciences announced today that the company's Decipher® Prostate Cancer Classifier will be featured in multiple sessions during the American Urological Association (AUA) Annual Meeting taking place May 16-21 in Orlando, FL. Two data presentations will detail validation studies supporting the use of Decipher to predict risk of metastasis in men following prostate surgery. Decipher has also been included in independent CME and educational...

New Prostate Cancer Test May Remove The Need For Painful Biopsies
2014-04-08 09:00:53

April Flowers for redOrbit.com - Your Universe Online Globally, over one million men a year have prostate tissue samples taken to check for signs of prostate cancer. This procedure can involve up to 12 large biopsy needles and has been called barbaric by Mayo Graduate School of Medicine Professor Matthew Gettman. As well, it reveals that 70 percent of the men undergoing the procedure do not have cancer. Beyond being unnecessarily painful and risky for the patient, the procedure is...

2014-04-07 12:47:39

A new genetic "signature" to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). Professor Robert Bristow will tell the conference that although surgery and precision radiotherapy are the mainstays of treatment for cancer that is confined to the prostate, the cancer...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.